Literature DB >> 32265102

ASIA syndrome and endocrine autoimmune disorders.

Nicola Luigi Bragazzi1, Ashraf Hejly2, Abdulla Watad3, Mohammed Adawi4, Howard Amital3, Yehuda Shoenfeld5.   

Abstract

An adjuvant is an immunological or pharmacological substance or group of substances that can be added to a given agent to enhance its effect in terms of efficacy, effectiveness and potency. Different mechanisms have been hypothesized underlying the action of the adjuvant, including boosting immune (innate and adaptive) response: this generally results in sparing the necessary amount of the agent and can potentially reduce the frequency of the needed number of therapeutic interventions. Adjuvants can be commonly found in vaccines, immunization products, mineral oils, cosmetics, silicone breast implants and other therapeutic/medical devices, being usually safe and effective. However, in a fraction of genetically susceptible and predisposed subjects, the administration of adjuvants may lead to the insurgence of serious side-effects, called "autoimmune/inflammatory syndrome by adjuvants" (ASIA) or Shoenfeld's syndrome. The present review is aimed at focusing on the "endocrine pebbles" of the mosaic of autoimmunity and of the ASIA syndrome, collecting together 54 cases of sub-acute thyroiditis, 2 cases of Hashimoto's thyroiditis, 11 cases of primary ovarian failure/primary ovarian insufficiency, 13 cases of autoimmune diabetes type 1, and 1 case of autoimmune adrenal gland insufficiency occurred after exposure to adjuvants.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ASIA syndrome; endocrine autoimmune disorders; silicone breast implant; vaccine adjuvants

Year:  2020        PMID: 32265102     DOI: 10.1016/j.beem.2020.101412

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  39 in total

1.  SARS-Cov-2 vaccination and metabolic radionuclide therapy: document of the SEMNIM Endocrinology Working Group.

Authors:  M Negre Busó; A Rodríguez Gasen; È Torrent Llongarriu; M Estorch Cabrera
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2021-07-12       Impact factor: 1.359

2.  [SARS-Cov-2 vaccination and metabolic radionuclide therapy: document of the SEMNIM Endocrinology Working Group].

Authors:  M Negre Busó; A Rodríguez Gasen; È Torrent Llongarriu; M Estorch Cabrera
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2021-07-12       Impact factor: 1.359

Review 3.  An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.

Authors:  Alessio Facciolà; Giuseppa Visalli; Antonio Laganà; Angela Di Pietro
Journal:  Vaccines (Basel)       Date:  2022-05-22

4.  Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.

Authors:  Carlos King Ho Wong; Kristy Tsz Kwan Lau; Xi Xiong; Ivan Chi Ho Au; Francisco Tsz Tsun Lai; Eric Yuk Fai Wan; Celine Sze Ling Chui; Xue Li; Esther Wai Yin Chan; Le Gao; Franco Wing Tak Cheng; Sydney Chi Wai Tang; Ian Chi Kei Wong
Journal:  PLoS Med       Date:  2022-06-21       Impact factor: 11.613

Review 5.  Influence of COVID-19 vaccines on endocrine system.

Authors:  Ying Zhao; Xiaohong Wu
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

6.  Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report.

Authors:  Shuhei Morita; Tomoya Tsuji; Shohei Kishimoto; Shinsuke Uraki; Ken Takeshima; Hiroshi Iwakura; Hiroto Furuta; Masahiro Nishi; Hidefumi Inaba; Taka-Aki Matsuoka
Journal:  BMC Endocr Disord       Date:  2022-07-19       Impact factor: 3.263

Review 7.  Breast Implant Illness (BII): Real Syndrome or a Social Media Phenomenon? A Narrative Review of the Literature.

Authors:  Bishara Atiyeh; Saif Emsieh
Journal:  Aesthetic Plast Surg       Date:  2021-07-06       Impact factor: 2.326

8.  Subacute thyroiditis during the COVID-19 pandemic: a prospective study.

Authors:  A B Bahçecioğlu; Z C Karahan; B I Aydoğan; I A Kalkan; A Azap; M F Erdoğan
Journal:  J Endocrinol Invest       Date:  2022-01-13       Impact factor: 5.467

9.  Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.

Authors:  B Pla Peris; A Á Merchante Alfaro; F J Maravall Royo; P Abellán Galiana; S Pérez Naranjo; M González Boillos
Journal:  J Endocrinol Invest       Date:  2022-01-11       Impact factor: 5.467

10.  Graves Disease Following the SARS-CoV-2 Vaccine: Case Series.

Authors:  Michael A Weintraub; Barbara Ameer; Naina Sinha Gregory
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.